Evidence Hub

Formulation and evaluation of Oral Thin Film of Esomeprazole and Domperidone Using 32Factorial Design

Atul Gupta, Vinesh Kumar, Anil Kumar Goyal, Barkha Kumawat, Jyoti Agarwal

International Journal of Drug Delivery Technology, 2026

Abstract

This study focused on the formulation and evaluation of oral thin films (OTFs) containing Esomeprazole, a proton pump inhibitor, and Domperidone, a dopamine antagonist, for the management of gastrointestinal disorders. OTFs were developed to address limitations of conventional oral dosage forms, particularly for patients with swallowing difficulties, and to improve solubility, bioavailability, and patient compliance. Film-forming agents such as Hypromellose, Carbomer 974, and Polyvinyl Alcohol were employed, and key formulation parameters—mechanical strength, disintegration time, and drug release—were optimized. Physicochemical evaluations included thickness, weight variation, folding endurance, swelling index, drug content uniformity, and in-vitro disintegration and dissolution studies. A 3² full factorial design was used, with Hypromellose and Carbomer 974 concentrations as independent variables. Among the formulations, F3 exhibited optimal properties, with rapid disintegration (12 seconds), uniform drug content, and excellent dissolution profiles for both drugs. The findings highlight that OTFs offer a promising platform for delivering Esomeprazole and Domperidone, enabling precise dosing, rapid onset of action, and improved therapeutic efficacy, especially for pediatric and geriatric patients. This approach presents a viable alternative to conventional dosage forms in gastrointestinal therapy

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free